Literature DB >> 21340160

A novel GNAS mutation in an infant boy with pseudohypoparathyroidism type Ia and normal serum calcium and phosphate levels.

Mariana Tenorio Antunes Reis1, Andreina Cattani, Berenice Bilharinho Mendonca, Pedro Henrique Silveira Corrêa, Regina Matsunaga Martin.   

Abstract

The objective of this study was to describe a new mutation in GNAS in a family with pseudohypoparathyroidism type Ia (PHP Ia), a rare osteometabolic disease. An 8-month-old boy was seen by an Endocrinologist due to obesity and low growth velocity. Noteworthy, his mother exhibited typical Albright hereditary osteodystrophy (AHO) phenotype. The clinical diagnosis of PHP Ia was suspected. The GNAS coding region from mother and son was amplified and directly sequenced. A novel heterozygous missense mutation (c.673T>C) was identified in exon 5 in both patients. In this family, the mother's clinical picture was the clue for the son's diagnosis. Molecular analysis of GNAS confirmed the diagnosis of PHP Ia in both patients and the child's early diagnosis was possible. Moreover, this novel missense substitution expands the spectrum of GNAS mutations associated with this disorder and allows for genetic counseling of this family.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21340160     DOI: 10.1590/s0004-27302010000800011

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  2 in total

1.  A patient with features of albright hereditory osteodystrophy and unusual neuropsychiatric findings without coding Gsalpha mutations.

Authors:  Shirin Hasani-Ranjbar; Zahra Jouyandeh; Mahsa Mohammad Amoli; Akbar Soltani; Seyed Masoud Arzaghi
Journal:  J Diabetes Metab Disord       Date:  2014-05-22

2.  Identification of a novel mutation in a patient with pseudohypoparathyroidism type Ia.

Authors:  Ye Seung Lee; Hui Kwon Kim; Hye Rim Kim; Jong Yoon Lee; Joong Wan Choi; Eun Ju Bae; Phil Soo Oh; Won Il Park; Chang Seok Ki; Hong Jin Lee
Journal:  Korean J Pediatr       Date:  2014-05-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.